Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Alice Houk"'
Autor:
Katherine W DiNardo, Alice Houk, Christine Shim, Kristen Backor, Erika Sloan, Jolien Sweere, Isabel N Schuermeyer, Mary K Hughes, Thomas W. Leblanc
Publikováno v:
Blood. 140:8122-8123
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0868d69cbe567cf1babc0d8d40381a1a
https://doi.org/10.1182/blood-2022-155893
https://doi.org/10.1182/blood-2022-155893
Autor:
Alice Houk, David J. King, Rodney A. Schmidt, Matthew Lesser, Ellen Salkeld, Christopher R. Cogle
Publikováno v:
Leukemia Research. 96:106425
Background Little is known about the shared decision-making between patients with transfusion-dependent (TD) myelodysplastic syndromes (MDS) and their physicians about the benefits, risks, and alternatives to reduce the need for blood transfusions. M
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c07e1d9f66548014b0a89f7df867b19
https://doi.org/10.1016/j.leukres.2020.106425
https://doi.org/10.1016/j.leukres.2020.106425
Publikováno v:
Expert Opinion on Orphan Drugs. 2:1171-1174
As new data from clinical trials and research studies are published about rare diseases, clinicians are challenged to stay abreast of the evidence, analyze it for clinical practice implications and then apply it to their medical practice. The Aplasti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cd6ebe85452b2d59e981523e60d1fd63
https://doi.org/10.1517/21678707.2014.966687
https://doi.org/10.1517/21678707.2014.966687
Autor:
David J. King, Matthew Lesser, Alice Houk, Martina Murphy, Christopher R. Cogle, Rodney A. Schmidt, Ellen Salkeld
Publikováno v:
Blood. 134:5418-5418
Background: According to claims-based studies, a minority of MDS patients receive disease-modifying therapy. Unfortunately, these studies are limited by design in describing the shared decision-making process between MDS patients and their physicians
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fe140caedbd4f7e273c39f72ab23cfbc
https://doi.org/10.1182/blood-2019-123474
https://doi.org/10.1182/blood-2019-123474
Autor:
Jamile M. Shammo, James M. Foran, Alice Houk, James Epstein, Mohit Narang, Pesha Rubinstein, Betsy Dennison, Joan M. Latsko, Gourishankar Naganna, John M. York
Publikováno v:
Cancer control : journal of the Moffitt Cancer Center. 18(1)
Background Myelodysplastic syndromes (MDS) comprise a heterogeneous group of hematologic malignancies, with an incidence rate of 3.4 cases per 100,000 in the United States. MDS affects patients predominantly over 60 years of age. As these syndromes a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a07e0601b22ea737cfa794823e1e1de
https://pubmed.ncbi.nlm.nih.gov/21273982
https://pubmed.ncbi.nlm.nih.gov/21273982
Autor:
Jaroslaw P. Maciejewski, John Huber, David P. Steensma, Richard Stone, Guillermo Garcia-Manero, Mikkael A. Sekeres, Alice Houk, Rami S. Komrokji, Betsy Dennison, Joan M. Latsko, Stephanie Chisolm, Aaron T. Gerds
Publikováno v:
Blood. 124:2642-2642
Background: MDS are a complex collection of diseases described with terminology that can be confusing for patients (pts) and limited treatment (tx) options. We previously reported on disparities in perceptions of disease characteristics and outcomes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::630d6f3cb07fe7e02d878c74b762dad6
https://doi.org/10.1182/blood.v124.21.2642.2642
https://doi.org/10.1182/blood.v124.21.2642.2642
Autor:
Aaron T. Gerds, Jaroslaw P. Maciejewski, John Huber, Guillermo Garcia-Manero, Joan M. Latsko, Betsy Dennison, Rami S. Komrokji, Stephanie Chisolm, Alice Houk, Richard Stone, Mikkael A. Sekeres, David P. Steensma
Publikováno v:
Blood. 124:6015-6015
Background: MDS is often described to patients (pts) with a diverse lexicon of terms such as refractory anemia, pre-leukemia, and blood disorder. Although MDS have long been recognized as clonal disorders and are classified as neoplastic by the World
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c355562924fb833fdf56c561dd9b90f5
https://doi.org/10.1182/blood.v124.21.6015.6015
https://doi.org/10.1182/blood.v124.21.6015.6015
Autor:
Stephanie J. Lee, Gregory A. Abel, Richard Stone, Nancy L. Young, Yolanda Martins, Robert J. Klaassen, B. Taylor Hastings, David P. Steensma, Alice Houk
Publikováno v:
Journal of Clinical Oncology. 30:6103-6103
6103 Background: Studies assessing the quality of life (QoL) experienced by patients with MDS have almost universally relied upon generic measures; however, disease-specific QoL tools can allow for more sensitive assessments of the impact of changes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::367d26cd413f277cc14d9741af29e543
https://doi.org/10.1200/jco.2012.30.15_suppl.6103
https://doi.org/10.1200/jco.2012.30.15_suppl.6103